President Donald Trump last week signed a bill to re-up the agreement between the FDA and the medical device and pharmaceutical industries, putting medical device companies in line for a collective $1 billion in user fees.
Companies pay user fees to help cover the cost of the safety watchdog’s reviews of their products. The bill to renew the agreement, the “
Go to Source